14 Years Manufacturer Rhodiola Rosea Extract Factory for Guinea


Product Detail

Product Tags

Related Video

Feedback (2)

Sticking to the perception of "Creating products of top of the range and earning mates with people today from all over the world", we constantly put the desire of consumers in the first place for 5 Htp 50 Mg Side Effects, Organic Fresh Royal Jelly, Glucomannan Weight Loss, Normally to the majority of business users and traders to offer best quality goods and excellent company. Warmly welcome to join us, let's innovation collectively, to flying dream.
14 Years Manufacturer Rhodiola Rosea Extract Factory for Guinea Detail:

[Latin Name] Rhodiola Rosea

[Plant Source] China

[Specifications] Salidrosides:1%-5%

Rosavin:3% HPLC

[Appearance] Brown fine powder

[Plant Part Used] Root

[Particle size] 80 Mesh

[Loss on drying] ≤5.0%

[Heavy Metal] ≤10PPM

[Storage] Store in cool & dry area, keep away from the direct light and heat.

[Package] Packed in paper-drums and two plastic-bags inside.

Rhodiola Rosea Extrac11t

[What is Rhodiola Rosea]

Rhodiola Rosea (also known as Arctic root or golden root) is a member of the family Crassulaceae, a family of plants native to the arctic regions of Eastern Siberia. Rhodiola rosea is widely distributed  in Arctic and mountainous regions throughout Europe and Asia. It grows at altitudes of 11,000 to 18,000 feet above sea level.

There are numerous animal and test tube studies showing that rhodiola has both a stimulating and a sedating effect on the central nervous system; enhance physical endurance; improves thyroid, thymus, and adrenal function; protects the nervous system, heart and liver; and has antioxidant and anticancer properties.

Rhodiola Rosea Extrac221t

[Function]

1 Enhancing immunity and delaying aging;

2 Resisting radiation and tumor;

3 Regulating nervous system and metabolism, effectively limiting melancholy feeling and mood, and promoting mental status;

4 Protecting cardiovascular, dilating coronary artery,preventing coronary arteriosclerosis and arrhythmia.


Product detail pictures:

14 Years Manufacturer Rhodiola Rosea Extract Factory for Guinea detail pictures


Related Product Guide:

Innovation, excellent and reliability are the core values of our business. These principles today extra than ever form the basis of our success as an internationally active mid-size company for 14 Years Manufacturer Rhodiola Rosea Extract Factory for Guinea , The product will supply to all over the world, such as: Malta, Turkey, Portland, We are proud to supply our products to every costumer all around the world with our flexible, fast efficient services and strictest quality control standard which has always approved and praised by customers.


  • 1-800-827-2638 – Call my free 5-minute recorded message (USA and Canada only) – 1-800-827-2638

    Click here for all the details about Elev8: https://BEpic4Life.com/?id=goforit

    Let’s connect.. Reach out to me TODAY!

    Here is more contact info:

    Mobile: 650-863-1945 call/text (USA/Canada and WhatsApp)

    Email: chrismclaughlin408@gmail.com

    Facebook: https://facebook.com/chrism1975

    Look forward to connecting with you! :)

    Elev8 Ingredients Information:

    Whole Food Derived Fruit and Vegetable Nutrient Extract Blend:
    Spinach, Broccoli, Carrot, Tomato, Beet, Shiitake Mushroom, Apple, Cranberry, Cherry, Orange, Blueberry, Strawberry

    Nature’s Energy & Clarity Blend:
    Guarana Seed Extract, Bacopa Monnieri 45%, L-Theanine, Caffeine, Green Coffee Bean Extract, Yohimbine hcl (5 mg), Thiamine hcl, Niacinamide, D-Calcium Pantothenate, Riboflavin, B12 Methylcobalamine

    Adaptogen Super Blend:
    Reishi Mushroom Extract, Chaga Extract, Rhodiola Rosea Extract, Cordyceps Extract

    Bioavailability Booster Blend:
    Trace Mineral Blend, Black Pepper Extract

    Vitamin A, C, D, E, K1, B1, B2, B3, B5, B6, B12, B7, B9

    b-epic review
    bepic
    elev8 b-epic
    bepic



    Title: Pneumococcal infections and vaccination.
    4th International Conference on Vaccines & Vaccination
    September 24-26, 2014 Valencia, Spain

    OMICS International: https://omicsonline.org
    Vaccine Conferences: https://conferenceseries.com/immunolog…
    Global Medical Conferences: https://conferenceseries.com
    Global Pharmaceutical Conferences: https://pharmaceuticalconferences.com
    Global Cancer Conferences: https://cancersummit.org
    Global Diabetes Conferences: https://diabetesexpo.com
    Global Dental Conferences: https://dentalcongress.com
    Global Nursing Conferences: https://nursingconference.com

    Abstract
    Pneumococci are major contributors to morbidity and mortality worldwide. They are the major cause of milder respiratory tract infections such as otitis and sinusitis, but also to more severe invasive infections such as community-acquired pneumonia with associated septicemia and meningitis. Even though being a devastating pathogen, pneumococci are also common colonizers of the upper respiratory tract of healthy children where from they may spread to cause disease. Risk groups for acquiring an invasive pneumococcal infection (IPD) include preschool children and the elderly, as well as immunocompromised individuals, splenectomised, and patients with a previous influenza virus infection. Several bacterial virulence factors have been described for pneumococci of which a major one is the capsular polysaccharide. Depending on differences in these capsular structures so far more than 90 different serotypes have been distinguished. Recently so called conjugated vaccines (PCV) have been introduced into the child hood vaccination program in many countries. These vaccines are based on a limited amount (7, 10 or 13) of the capsular serotypes. In Sweden PCVs were introduced in the whole of Sweden year 2009. Vaccine introduction has led to a reduction in the incidence of IPD in vaccinated children but also to serotype replacementand an increase of non-vaccine type disease.

    Biography

    Birgitta Henriques Normark is professor and head physician in Clinical microbiology at Karolinska Institute and Karolinska University hospital, as well as head physician at the Public Health Agency of Sweden. She is also vice dean for recruitment at Karolinska Institutet and a board member of the Swedish Research Council, Medicine and Health.Her research focuses on epidemiology, antibiotic resistance and host-microbe interactions in bacterial infections with special focus on pneumococcal epidemicity, molecular epidemiology, and mechanisms of invasive disease, innate immunity and host-microbe interactions determining disease outcome. The research has been published in 136 publications of which 107 are original peer reviewed articles.

    The company's products very well, we have purchased and cooperated many times, fair price and assured quality, in short, this is a trustworthy company!
    5 Stars By Mildred from Turin - 2017.07.28 15:46
    The sales person is professional and responsible, warm and polite, we had a pleasant conversation and no language barriers on communication.
    5 Stars By Ida from Kyrgyzstan - 2018.09.16 11:31
    Write your message here and send it to us